The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

The company is at a pivotal point following the killing of Brian Thompson, who headed the UnitedHealthcare unit, and there was a public outcry about insurance denials. That prompted Andrew Witty, the ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

UnitedHealth shares have been pressured recently, falling about 10% since Dec. 4, when Thompson was killed. That outpaces the 3% drop in the S&P 500 index over that span and signals some investor ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

The U.S. Food and Drug Administration today issued a proposed rule to limit nicotine levels in cigarettes and other combusted (smoked) tobacco products to minimally addictive or non-addictive levels, ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

A new report published by THE SAGE GROUP reviews recent calcium research and quantifies the number of CLI patients with calcified leg arteries. "Almost all CLI patients have arterial calcification.

The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...

Pharmacy benefit managers "are raking in billions in excess revenue—$7.3 billion over just five years—while squeezing ...

They are also demanding of Apple something called interoperability, which absurdly requires Apple to hand over access to its private operating systems to its competitors and will require iPhones to ...